现代诊断与治疗
現代診斷與治療
현대진단여치료
MODERN DIAGNOSIS AND TREATMENT
2015年
4期
723-725,726
,共4页
何红秋%周永军%章佳慧%李顺开
何紅鞦%週永軍%章佳慧%李順開
하홍추%주영군%장가혜%리순개
脱氧核苷酸注射液%开放性骨折%创面%感染
脫氧覈苷痠註射液%開放性骨摺%創麵%感染
탈양핵감산주사액%개방성골절%창면%감염
ODN injection%Open fracture%Wound%Infection factor%Open fractures%Wounds%Infec-tions
目的:观察脱氧核苷酸注射液联合负压引流技术(VSD)治疗开放性骨折的有效性与安全性。方法入选我院48例开放性骨折患者,所有患者相应的外固定、VSD、皮瓣移植、抗感染、消肿及抗凝治疗。治疗组24例在基础治疗上给予脱氧核苷酸注射液冲洗联合静脉滴注。对照组24例在基础治疗上给予生理盐水治疗。结果治疗组创面完全愈合时间,骨折愈合时间(d),骨折延迟愈合发生率,皮片成活面积(%)分别为25.7±7.8,71.2±21.2,0%,97.2±2.4%;对照组分别为31.4±7.4,77.9±23.2,16.7%,89.6±2.8%;两组比较具有统计学差异(P<0.05)。另外rh-aFGF治疗后,治疗组水肿评分、疼痛评分、中重度感染发生率分别为2.0±0.2,1.6±0.2,8.3%;对照组分别为3.8±0.6,3.7±0.2,50.0%;两组比较具有统计学差异(P<0.05)。治疗过程中,两组均未发生明显的不良反应。结论脱氧核苷酸注射液与VSD联合治疗,可加速创面愈合,减轻手术后并发症,减少感染发生。
目的:觀察脫氧覈苷痠註射液聯閤負壓引流技術(VSD)治療開放性骨摺的有效性與安全性。方法入選我院48例開放性骨摺患者,所有患者相應的外固定、VSD、皮瓣移植、抗感染、消腫及抗凝治療。治療組24例在基礎治療上給予脫氧覈苷痠註射液遲洗聯閤靜脈滴註。對照組24例在基礎治療上給予生理鹽水治療。結果治療組創麵完全愈閤時間,骨摺愈閤時間(d),骨摺延遲愈閤髮生率,皮片成活麵積(%)分彆為25.7±7.8,71.2±21.2,0%,97.2±2.4%;對照組分彆為31.4±7.4,77.9±23.2,16.7%,89.6±2.8%;兩組比較具有統計學差異(P<0.05)。另外rh-aFGF治療後,治療組水腫評分、疼痛評分、中重度感染髮生率分彆為2.0±0.2,1.6±0.2,8.3%;對照組分彆為3.8±0.6,3.7±0.2,50.0%;兩組比較具有統計學差異(P<0.05)。治療過程中,兩組均未髮生明顯的不良反應。結論脫氧覈苷痠註射液與VSD聯閤治療,可加速創麵愈閤,減輕手術後併髮癥,減少感染髮生。
목적:관찰탈양핵감산주사액연합부압인류기술(VSD)치료개방성골절적유효성여안전성。방법입선아원48례개방성골절환자,소유환자상응적외고정、VSD、피판이식、항감염、소종급항응치료。치료조24례재기출치료상급여탈양핵감산주사액충세연합정맥적주。대조조24례재기출치료상급여생리염수치료。결과치료조창면완전유합시간,골절유합시간(d),골절연지유합발생솔,피편성활면적(%)분별위25.7±7.8,71.2±21.2,0%,97.2±2.4%;대조조분별위31.4±7.4,77.9±23.2,16.7%,89.6±2.8%;량조비교구유통계학차이(P<0.05)。령외rh-aFGF치료후,치료조수종평분、동통평분、중중도감염발생솔분별위2.0±0.2,1.6±0.2,8.3%;대조조분별위3.8±0.6,3.7±0.2,50.0%;량조비교구유통계학차이(P<0.05)。치료과정중,량조균미발생명현적불량반응。결론탈양핵감산주사액여VSD연합치료,가가속창면유합,감경수술후병발증,감소감염발생。
Objective Observation ODN injection combined with vacuum assisted(VSD) open fracture treatment effectiveness and safety.Methods 48 cases of open fractures enrolled patients in our hospital, the corresponding external fixation,VSD and flap transplantation in the treatment of all patients.Results Treated the wounds healing time, fracture healing time (d), the incidence of de-layed union fractures, skin graft survival area (%) were 25.7 ±7.8,71.2 ±21.2,0%, 97.2 ±2.4%; the control group were 31.4 ±7.4,77.9 ±23.2,16.7%,89.6 ±2.8%; compare the two groups was significant difference (P<0.05). Also after rh-aFGF treatment group edema score, pain score, the incidence of severe infection was 2.0 ± 0.2,1.6 ± 0.2,8.3%, respectively; the control group was 3.8 ± 0.6,3.7± 0.2,50.0%; two Comparison with a statistically significant difference (P<0.05). The course of treat-ment, the two groups were not significant adverse reactions.Conclusions ODN injection and VSD combination therapy, can accelerate wound healing and reduce post-surgical complications, reduce infection.